| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.093 | 0.1 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.088 | 0.1 |